The development of novel inhibitors of tumor necrosis factor-α (TNF-α) production based on substituted [5,5]-bicyclic pyrazolones

被引：21

作者：

Laufersweiler, MJ ^{[1
]}

Brugel, TA ^{[1
]}

Clark, MP ^{[1
]}

Goleblowski, A ^{[1
]}

Bookland, RG ^{[1
]}

Laughlin, SK ^{[1
]}

Sabat, MP ^{[1
]}

Townes, JA ^{[1
]}

VanRens, JC ^{[1
]}

De, B ^{[1
]}

Hsieh, LC ^{[1
]}

Heitmeyer, SA ^{[1
]}

Juergens, K ^{[1
]}

Brown, KK ^{[1
]}

Mekel, MJ ^{[1
]}

Walter, RL ^{[1
]}

Janusz, MJ ^{[1
]}

机构：

[1] Procter & Gamble Pharmaceut, Hlth Care Res Ctr, Mason, OH 45040 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 16期

关键词：

TNF-alpha; cytokine synthesis inhibition; pyrazolones; p38; kinases;

D O I：

10.1016/j.bmcl.2004.06.001

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Novel substituted [5,5]-bicyclic pyrzazolones are presented as inhibitors of tumor necrosis factor-alpha (TNF-alpha) production. Many of these compounds show low nanomolar activity against lipopolysaccaride (LPS)-induced TNF-alpha production in THP-1 cells. This class of molecules was co-crystallized with mutated p38, and several analogs showed good oral bioavailability in the rat. Oral activity of these compounds in the rat iodoacetate model for osteoarthritis is discussed. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：4267 / 4272

页数：6

共 50 条

[21] Altered tumor necrosis factor-α (TNF-α) processing in adipocytes and increased expression of transmembrane TNF-α in obesity
Xu, HY
Uysal, KT
Becherer, JD
Arner, P
Hotamisligil, GS
DIABETES, 2002, 51 (06) : 1876 - 1883
[22] The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
Jang, Dan-in
Lee, A-Hyeon
Shin, Hye-Yoon
Song, Hyo-Ryeong
Park, Jong-Hwi
Kang, Tae-Bong
Lee, Sang-Ryong
Yang, Seung-Hoon
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (05) : 1 - 16
[23] Tumor necrosis factor-α (TNF-α) and TNF-α receptor R1 in peripheral ulcerative keratitis (PUK)
Chandrupatla, CV
Grover, S
Edward, DP
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U331 - U331
[24] Plasma concentrations of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in patients with anorexia nervosa
Nakai, Y
Hamagaki, S
Takagi, R
Taniguchi, A
Kurimoto, F
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04): : 1226 - 1228
[25] Plasma concentrations of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in patients with bulimia nervosa
Nakai, Y
Hamagaki, S
Takagi, R
Taniguchi, A
Kurimoto, F
CLINICAL ENDOCRINOLOGY, 2000, 53 (03) : 383 - 388
[26] Humanization of a mouse neutralizing monoclonal antibody against tumor necrosis factor-α (TNF-α)
Nagahira, K
Fukuda, Y
Oyama, Y
Kurihara, T
Nasu, T
Kawashima, H
Noguchi, C
Oikawa, S
Nakanishi, T
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 222 (1-2) : 83 - 92
[27] Tumor necrosis factor-α and TNF-β inhibit clonogenicity of mobilized human hematopoietic progenitors
Skobin, V
Jelkmann, W
Morschakova, E
Pavlov, AD
Schlenke, P
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2000, 20 (05): : 507 - 510
[28] Tumor Necrosis Factor-α (TNF-α) Influence in Pathogenesis of Childhood Primary Immune Thrombocytopenia
Hesham, Mervat Abdallah
Esh, Asmaa Mohamed Husny
Beshik, Ahmed Mokhtar
BIOSCIENCE RESEARCH, 2020, 17 (04): : 4241 - 4247
[29] Thalidomide promotes the release of tumor necrosis factor-α (TNF-α) and lethality by lipopolysaccharide in mice
Ishikawa, M
Kanno, S
Takayanagi, M
Takayanagi, Y
Sasaki, K
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1998, 21 (06) : 638 - 640
[30] Tumor necrosis factor-α (TNF-α) stimulates chemotactic response in mouse myogenic cells
Torrente, Y
El Fahime, E
Caron, NJ
Del Bo, R
Belicchi, M
Pisati, F
Tremblay, JP
Bresolin, N
CELL TRANSPLANTATION, 2003, 12 (01) : 91 - 100

← 1 2 3 4 5 →